Thrombotic thrombocytopenic purpura induced by trimethoprim- sulfamethoxazole in a Jehovah's Witness

17Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report a case of Thrombotic Thrombocytopenic Purpura occurring as an allergic response to trimethoprim-sulfamethoxazole therapy (Bactrim™, Septra®) in a Jehovah's Witness patient. The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim-sulfamethoxazole. Other symptoms of drug hypersensitivity included nausea, vomiting, urticarial rash, and leukopenia. Because of her religious faith, the patient was supported without plasma therapy with use of intravenous immunoglobulin, steroids, rituximab, and erythropoietin. © 2007 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Martin, M. G., Whitlatch, N. L., Shah, B., & Arepally, G. M. (2007). Thrombotic thrombocytopenic purpura induced by trimethoprim- sulfamethoxazole in a Jehovah’s Witness. American Journal of Hematology, 82(7), 679–681. https://doi.org/10.1002/ajh.20887

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free